[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100369291":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":53,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Ruijin Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"B-cell lymphoma",null,[12],"Procedure: peripheral blood collection",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"PROCEDURE","peripheral blood collection","peripheral blood collection at treatment start, interm PET\u002FCT, end of treatment PET\u002FCT, one-year and two-year follow-up and or progression or relapse",[9],[20],{"name":21,"affiliation":5,"role":22},"Weili Zhao, MD，PhD","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":27,"email":28},"CONTACT","64370045","610707","zhao.weili@yahoo.com",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Ruijin hospital","RECRUITING","Shanghai","Shanghai Municipality","200025","China","CN",{"type":39,"coordinates":40},"Point",[41,42],121.45806,31.22222,{"lat":42,"lon":41},[45,49,51],{"name":46,"role":25,"phone":47,"phoneExt":27,"email":48},"Pengpeng XU, MD, PhD","86-21-64370045","xpproc@msn.com",{"name":50,"role":22,"phone":10,"phoneExt":10,"email":10},"Weili ZHAO, MD, PhD",{"name":46,"role":52,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":22,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Zhao Weili","Professor","100369291","cell-free-dna-in-mature-b-cell-lymphoma-100369291",false,"NCT04088422","Cell Free DNA in Mature B-cell Lymphoma","Prospective, Observational Study on Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Lymphoma Management","Inclusion Criteria:\n\n* Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria\n* 18 years or older\n\nExclusion Criteria:\n\n* Chemotherapy before\n* Other tumors","ALL","18 Years",{"count":66,"type":67},320,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.",[71],"Mature B-Cell Lymphoma","2023-02-23",{"date":74,"type":75},"2023-02-24","ACTUAL",{"date":77,"type":75},"2022-09-28",{"date":79,"type":67},"2026-12",{"name":5,"class":6},1]